Shares of the leading robotic surgery device makers all fell today, after a Massachusetts medical board issued an advisory to surgeons warning of possible risks with the cutting-edge technology.
MAKO Surgical Corp.
BlackRock Inc., 1 of the world’s largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.
The U.S. robot-assisted surgery space added a new player this week with FDA clearance for Blue Belt Technologies’ NavioPFS orthopedic surgery system.
The Pittsburgh, Pa.-based device maker won clearance with indication for partial knee replacement, a procedure generally performed using manual instruments, the company noted.
Mako said last week that the offering, priced at $13.15 per share for more than 3 million shares, would go toward "commercialization infrastructure" and to cover other corporate expenses.